secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0001628280-22-031597
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead Pharmaceuticals raises ~$250M via equity offering of 7.8M shares through Jefferies
--------------------------------------------------------------------------------

- Entered Open Market Sale Agreement with Jefferies LLC to sell up to 7,807,620 shares of common stock.
- Estimated gross proceeds of ~$250 million after discounts, commissions, and expenses.
- Offering closed on December 2, 2022; shares issued under shelf registration statement on Form S-3.
- Company agreed to indemnify Jefferies against certain liabilities under the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828022031597/0001628280-22-031597-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828022031597/arwr-20221202.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-031597

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer